David Clemow
Eli Lilly and Company
Advisor, Scientific Communications Information Strategy
David is an Advisor Scientific Communications Information Strategy at Eli Lilly and Company with over 20 years of regulatory, publication, and promotional scientific communications experience in the pharmaceutical industry. His work has included document authoring, team management, operations consulting, clinical research, and medical affairs. David is Chair of DIA’s Medical Writing Community and Community Leadership Council, as well as the American Medical Writers Association Medical Writing Certification Commission.